IP21-02: 3-MONTH OUTCOMES FROM A PROSPECTIVE, MULTI-CENTER, OPEN-LABEL STUDY EVALUATING A NOVEL DELIVERY SYSTEM WHEN DEPLOYING THE PROVEE PROSTATIC URETHRAL STENT FOR THE TREATMENT OF BPH

IP21-02: 3-MONTH OUTCOMES FROM A PROSPECTIVE, MULTI-CENTER, OPEN-LABEL STUDY EVALUATING A NOVEL DELIVERY SYSTEM WHEN DEPLOYING THE PROVEE PROSTATIC URETHRAL STENT FOR THE TREATMENT OF BPH

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!